Proteome Sciences plc (AIM: PRM)
London
· Delayed Price · Currency is GBP · Price in GBX3.560
+0.050 (1.42%)
Sep 10, 2024, 12:05 PM GMT+1
Proteome Sciences Cash Flow Statement
Financials in millions GBP. Fiscal year is January - December.
Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | -2.44 | -2.44 | 1.33 | 0.07 | 0.3 | 0.15 | Upgrade
|
| Depreciation & Amortization | 0.48 | 0.48 | 0.28 | 0.21 | 0.17 | 0.09 | Upgrade
|
| Stock-Based Compensation | 0.22 | 0.22 | 0.3 | 0.57 | 0.01 | 0.08 | Upgrade
|
| Other Operating Activities | 0.81 | 0.81 | 0.59 | 0.27 | 0.3 | 0.34 | Upgrade
|
| Change in Accounts Receivable | 0.7 | 0.7 | -0.92 | 0.16 | 0.57 | -1.17 | Upgrade
|
| Change in Inventory | 0.06 | 0.06 | 0.19 | -0.21 | -0.01 | 0.28 | Upgrade
|
| Change in Accounts Payable | -0.3 | -0.3 | 0.29 | -0.29 | 0.16 | 0.2 | Upgrade
|
| Change in Other Net Operating Assets | -0.02 | -0.02 | 0.08 | 0.01 | 0.09 | 0.06 | Upgrade
|
| Operating Cash Flow | -0.48 | -0.48 | 2.14 | 0.79 | 1.58 | 0.02 | Upgrade
|
| Operating Cash Flow Growth | - | - | 169.86% | -49.91% | 7815.00% | - | Upgrade
|
| Capital Expenditures | -0.24 | -0.24 | -0.32 | -0.2 | -0.01 | -0.06 | Upgrade
|
| Other Investing Activities | -0.19 | -0.19 | - | - | - | - | Upgrade
|
| Investing Cash Flow | -0.42 | -0.42 | -0.32 | -0.2 | -0.01 | -0.06 | Upgrade
|
| Short-Term Debt Repaid | -0.82 | -0.82 | - | - | - | - | Upgrade
|
| Long-Term Debt Repaid | -0.24 | -0.24 | -0.21 | -0.4 | -0.15 | -0.06 | Upgrade
|
| Total Debt Repaid | -1.06 | -1.06 | -0.21 | -0.4 | -0.15 | -0.06 | Upgrade
|
| Net Debt Issued (Repaid) | -1.06 | -1.06 | -0.21 | -0.4 | -0.15 | -0.06 | Upgrade
|
| Financing Cash Flow | -1.06 | -1.06 | -0.21 | -0.4 | -0.15 | -0.06 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | - | -0.01 | -0.01 | -0.01 | -0.06 | Upgrade
|
| Net Cash Flow | -1.97 | -1.97 | 1.61 | 0.18 | 1.41 | -0.16 | Upgrade
|
| Free Cash Flow | -0.72 | -0.72 | 1.82 | 0.59 | 1.57 | -0.04 | Upgrade
|
| Free Cash Flow Growth | - | - | 209.17% | -62.48% | - | - | Upgrade
|
| Free Cash Flow Margin | -14.28% | -14.28% | 23.41% | 11.48% | 33.03% | -0.82% | Upgrade
|
| Free Cash Flow Per Share | -0.00 | -0.00 | 0.01 | 0.00 | 0.01 | -0.00 | Upgrade
|
| Cash Income Tax Paid | 0.03 | 0.03 | -0.07 | 0.05 | -0.05 | -0.19 | Upgrade
|
| Levered Free Cash Flow | -0.58 | -0.58 | 0.61 | 0.32 | 1.04 | -0.6 | Upgrade
|
| Unlevered Free Cash Flow | -0.08 | -0.08 | 0.91 | 0.5 | 1.23 | -0.39 | Upgrade
|
| Change in Net Working Capital | -0.47 | -0.47 | 0.44 | 0.34 | -0.72 | 0.7 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.